Bladder Instillations With Triamcinolone Acetonide for Interstitial Cystitis-Bladder Pain Syndrome: A Randomized...

Area of Science:

• Urology
• Pharmacology

Background:

• Interstitial cystitis-bladder pain syndrome (IC-BPS) significantly impacts quality of life.
• Standard bladder instillation therapy aims to alleviate IC-BPS symptoms.
• Investigating novel therapeutic additions is crucial for effective IC-BPS management.

Purpose of the Study:

• To determine if adding triamcinolone acetonide to a standard bladder instillation solution enhances treatment efficacy for IC-BPS.
• To compare symptom improvement in IC-BPS patients receiving standard instillations versus those with triamcinolone acetonide.

Main Methods:

• A single-center, randomized, double-blind trial was conducted.
• 90 women with IC-BPS received six bladder instillations, either with or without triamcinolone acetonide.
• Symptom response was assessed using the O'Leary-Sant Questionnaire (OLS) score.

Main Results:

• No statistically significant difference in symptom improvement was observed between the triamcinolone acetonide group and the control group (P=.31).
• Both groups demonstrated improvement in IC-BPS symptoms, indicated by a decrease in total OLS scores.
• 71 out of 90 participants completed the full six-instillation treatment course.

Conclusions:

• The addition of triamcinolone acetonide to standard bladder instillations does not offer additional benefit for treating IC-BPS symptoms.
• Standard bladder instillations alone may provide symptom relief for some IC-BPS patients.
• Further research may explore alternative or combination therapies for refractory IC-BPS cases.